Cite
Multikinase inhibitor sorafenib prevents pressure overload-induced left ventricular hypertrophy in rats by blocking the c-Raf/ERK1/2 signaling pathway.
MLA
Daryadel, Arezoo, et al. “Multikinase Inhibitor Sorafenib Prevents Pressure Overload-Induced Left Ventricular Hypertrophy in Rats by Blocking the c-Raf/ERK1/2 Signaling Pathway.” Journal of Cardiothoracic Surgery, vol. 9, no. 1, May 2014, pp. 1–21. EBSCOhost, https://doi.org/10.1186/1749-8090-9-81.
APA
Daryadel, A., Bogdanova, A., Gassmann, M., Mueller, X., Zünd, G., Seifert, B., Lehalle, C., Frossard, N., & Tavakoli, R. (2014). Multikinase inhibitor sorafenib prevents pressure overload-induced left ventricular hypertrophy in rats by blocking the c-Raf/ERK1/2 signaling pathway. Journal of Cardiothoracic Surgery, 9(1), 1–21. https://doi.org/10.1186/1749-8090-9-81
Chicago
Daryadel, Arezoo, Anna Bogdanova, Max Gassmann, Xavier Mueller, Gregor Zünd, Burkhardt Seifert, Christine Lehalle, Nelly Frossard, and Reza Tavakoli. 2014. “Multikinase Inhibitor Sorafenib Prevents Pressure Overload-Induced Left Ventricular Hypertrophy in Rats by Blocking the c-Raf/ERK1/2 Signaling Pathway.” Journal of Cardiothoracic Surgery 9 (1): 1–21. doi:10.1186/1749-8090-9-81.